Publication | Open Access

Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling

Drug TargetSignal TransductionSignaling PathwayMedicineReceptor Tyrosine KinaseNucleotide-binding Oligomerization DomainReceptor (Biochemistry)Mechanism Of ActionSystems BiologyPharmacologyCell SignalingDrug Discovery